Prof. Dr. med. Arndt Hartmann



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Frequency of TERT Promoter Mutations in Prostate Cancer (2015) Stoehr R, Taubert H, Zinnall U, Giedl J, Gaisa NT, Burger M, Ruemmele P, et al. Journal article Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes (2015) Agaimy A, Haller F, Frohnauer J, Schaefer IM, Stroebel P, Hartmann A, Stoehr R, Kloeppel G Journal article Impaired T-bet-pSTAT1? and perforin-mediated immune responses in the tumoral region of lung adenocarcinoma (2015) Andreev K, Trufa D, Siegemund R, Rieker R, Hartmann A, Schmidt J, Sirbu H, Finotto S Journal article The combined serum levels of miR-375 and urokinase plasminogen activator receptor are suggested as diagnostic and prognostic biomarkers in prostate cancer (2015) Wach S, Al-Janabi O, Weigelt K, Fischer K, Greither T, Marcou M, Theil G, et al. Journal article miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis (2015) Benderska N, Dittrich AL, Knaup S, Rau T, Neufert C, Wach S, Fahlbusch FB, et al. Journal article Sclerosing epithelioid fibrosarcoma of the kidney: clinicopathologic and molecular study of a rare neoplasm at a novel location (2015) Ohlmann CH, Brecht IB, Junker K, Van Der Zee JA, Nistor A, Bohle RM, Stöckle M, et al. Journal article Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients (2015) Rauh C, Schuetz F, Rack B, Stickeler E, Klar M, Orlowska-Volk M, Windfuhr-Blum M, et al. Journal article VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis (2015) Försch S, Sperka T, Lindner C, Taut A, Rudolph KL, Breier G, Boxberger F, et al. Journal article Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial (2015) Erber R, Gluz O, Brünner N, Kreipe HH, Pelz E, Kates R, Bartels A, et al. Journal article Molecular Characterisation of Urothelial Bladder Cancer: Will it Improve Patient Care? (2015) Erben P, Hartmann A, Bolenz C Journal article